Skip to main content
Semler Scientific, Inc. logo

Semler Scientific, Inc. — Investor Relations & Filings

Ticker · SMLR ISIN · US81684M1045 LEI · 549300ZHL16S29QTW485 US Professional, scientific and technical activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2016-02-22 Director's Dealing
Country US United States of America
Listing US SMLR

About Semler Scientific, Inc.

https://www.semlerscientific.com/

Semler Scientific, Inc. is a company that develops, manufactures, and markets technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Its primary focus is on products and services that support the early detection and treatment of chronic diseases. The company's flagship product is a patented, FDA-cleared system that provides a rapid, point-of-care test to aid in the diagnosis of peripheral artery disease (PAD). In addition to its healthcare technology operations, the company has adopted a corporate strategy to acquire and hold bitcoin as its primary treasury reserve asset.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2016-02-22 English
OWNERSHIP DOCUMENT
Director's Dealing
2016-02-22 English
OWNERSHIP DOCUMENT
Director's Dealing
2016-02-22 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions Item 2.02, which is "Results of Operations and Financial Condition," and states that the company issued a press release announcing its financial results for the fourth quarter and year ended 2015. The document includes a press release as Exhibit 99.1 but does not contain the full financial results itself. The length of the document is 3358 characters, which is relatively short and mainly serves to announce the earnings release rather than provide detailed financial statements or analysis. According to the classification rules, initial announcements of quarterly or periodical financial results (key highlights only) are classified as Earnings Release (ER). Therefore, this document is best classified as an Earnings Release (ER).
2016-02-19 English
FORM 8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The content specifically discusses a notice of delisting from NASDAQ due to failure to meet listing requirements, the company's appeal process, and the status of the listing. The key section is 'Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.' This matches the definition of a Delisting Announcement (DLST). The document is about the delisting event itself, not a report or other type of filing. The length and detail confirm it is the announcement, not a brief notice or a report publication announcement. Therefore, the correct classification is DLST with high confidence.
2016-02-16 English
AMENDMENT NO. 2 TO SCHEDULE 13G
Major Shareholding Notification
2016-02-16 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.